XTX Topco’s Basel Medical BMGL Stock Holding History

XTX Topco’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,146	Closed	-$15.7K	–	4853
2026 Q1	$15.7K	Sell	2,146 -390	-15%	-$3.08K	﹤0.01%	3607
2025 Q4	$14.9K	Buy	+2,536	New	+$37.4K	﹤0.01%	3122

Other funds holding BMGL

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco's BMGL Position: Q2 2026 in Review

XTX Topco sold out of Basel Medical (BMGL) in Q2 2026, closing a stake of 2,146 shares — an estimated $15.7K sold.

XTX Topco first reported a position in BMGL in Q4 2025 and held it in 2 quarters. The position peaked at $15.7K in Q1 2026. 2 funds tracked by Wall St. Rank hold BMGL as of Q2 2026.

XTX Topco reported no remaining Basel Medical position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 2,146 Basel Medical shares in Q2 2026, an estimated $15.7K.
XTX Topco first reported a position in Basel Medical in Q4 2025 and held it in 2 quarters.
XTX Topco's Basel Medical position peaked at $15.7K in Q1 2026.
2 funds tracked by Wall St. Rank held Basel Medical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.